The Pentraxins 1975–2018: Serendipity, Diagnostics and Drugs

PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer

(2018) Cecilia Garlanda et al.   PHYSIOLOGICAL REVIEWS

Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1

(2018) Nicola J. Borthwick et al.   PLoS One

Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis

(2018) Duncan B. Richards et al.   Science Translational Medicine

Serum Amyloid P Component Accelerates the Formation and Enhances the Stability of Amyloid Fibrils in a Physiologically Significant Under-Saturated Solution of Amyloid-β42

(2018) Matthew Mold et al.   JOURNAL OF ALZHEIMERS DISEASE

C-Reactive Protein Mediating Immunopathological Lesions: A Potential Treatment Option for Severe Influenza A Diseases

(2017) Rongbao Gao et al.   EBioMedicine

Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid depositsin vivo

(2016) Raya Al-Shawi et al.   Open Biology

Targeting C-Reactive Protein in Inflammatory Disease by Preventing Conformational Changes

(2015) J. R. Thiele et al.   MEDIATORS OF INFLAMMATION

Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component

(2015) Duncan B. Richards et al.   NEW ENGLAND JOURNAL OF MEDICINE

C-reactive protein is essential for innate resistance to pneumococcal infection

(2014) J. Paul Simons et al.   IMMUNOLOGY

Protection of Human Podocytes from Shiga Toxin 2-Induced Phosphorylation of Mitogen-Activated Protein Kinases and Apoptosis by Human Serum Amyloid P Component

(2014) Anne K. Dettmar et al.   INFECTION AND IMMUNITY

Selective apheresis of C-reactive protein: A new therapeutic option in myocardial infarction?

(2014) Ahmed Sheriff et al.   JOURNAL OF CLINICAL APHERESIS

Inhibiting C-Reactive Protein for the Treatment of Cardiovascular Disease: Promising Evidence from Rodent Models

(2014) Alexander J. Szalai et al.   MEDIATORS OF INFLAMMATION

Infusion of Pharmaceutical-Grade Natural Human C-Reactive Protein Is Not Proinflammatory in Healthy Adult Human Volunteers

(2013) Thirusha Lane et al.   CIRCULATION RESEARCH

Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C‐reactive protein, for clinical use

(2012) Mark B. Pepys et al.   JOURNAL OF IMMUNOLOGICAL METHODS

C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

A Selective Inhibitor of Human C-reactive Protein Translation Is Efficacious In Vitro and in C-reactive Protein Transgenic Mice and Humans

(2012) Nicholas R Jones et al.   Molecular Therapy-Nucleic Acids

Serum amyloid P component facilitates DNA clearance and inhibits plasmid transfection: implications for human DNA vaccine

(2011) Y Wang et al.   GENE THERAPY

Human Serum Amyloid P Functions as a Negative Regulator of the Innate and Adaptive Immune Responses to DNA Vaccines

(2011) Y. Wang et al.   JOURNAL OF IMMUNOLOGY

Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum

(2011) Andreas Charidimou et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Brain Serum Amyloid P Levels are Reduced in Individuals that Lack Dementia While Having Alzheimer’s Disease Neuropathology

(2011) Jeffrey R. Crawford et al.   NEUROCHEMICAL RESEARCH

Specific Removal of C-Reactive Protein by Apheresis in a Porcine Cardiac Infarction Model

(2010) Anna Christine Slagman et al.   BLOOD PURIFICATION

Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosis

(2010) Julian D. Gillmore et al.   BRITISH JOURNAL OF HAEMATOLOGY

Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli

(2010) M. B. PEPYS et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits

(2010) Karl Bodin et al.   NATURE

Decay-Accelerating Factor Attenuates C-Reactive Protein-Potentiated Tissue Injury After Mesenteric Ischemia/Reperfusion

(2009) Xinyue Lu et al.   JOURNAL OF SURGICAL RESEARCH

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

(2009)   LANCET

Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component

(2009) S. E. Kolstoe et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CRPgene variation and risk of community-acquired pneumonia

(2009) Kenneth J. MUKAMAL et al.   RESPIROLOGY

C-reactive protein and coronary heart disease: a critical review

(2008) J. P. Casas et al.   JOURNAL OF INTERNAL MEDICINE